'Adverse drug' diaporamas de présentation

Adverse drug - PowerPoint PPT Presentation

Jon Morris, MD, FACEP, MBA WellStar Health Systems

Jon Morris, MD, FACEP, MBA WellStar Health Systems

Emergency Room Of The Future Leveraging IT At WellStar Health System: Kennestone Emergency Department. September 18, 2008. Jon Morris, MD, FACEP, MBA WellStar Health Systems. Agenda. Introduction Kennestone Emergency Department Metrics More Metrics- Exit Phase

★ ★ ★ ★ ★

920 views • 72 slides
Quality Assessment of Drug Therapy

Quality Assessment of Drug Therapy

Quality Assessment of Drug Therapy. Charles E. Daniels, R.Ph., Ph.D. Pharmacist-In-Chief Professor of Clinical Pharmacy University of California San Diego, California. Patient Concerns. Drug-Drug interaction 70% Wrong medicine 69% Cost of treatment 69%

★ ★ ★ ★ ★

864 views • 64 slides
Looking for a Cheap and Easy Evidence-Based Program?

Looking for a Cheap and Easy Evidence-Based Program?

Looking for a Cheap and Easy Evidence-Based Program?. Partners in Care Foundation June Simmons, CEO Sandy Atkins, VP, Institute for Change. Presented By:. Sandy Atkins, VP Institute for Change Partners in Care Foundation Amy Adams, Manager Support Services B.S.

★ ★ ★ ★ ★

637 views • 51 slides
Clinical Analysis of Adverse Drug Reactions

Clinical Analysis of Adverse Drug Reactions

Clinical Analysis of Adverse Drug Reactions. Karim Anton Calis, Pharm.D., M.P.H. National Institutes of Health. Objectives. Define adverse drug reactions Discuss epidemiology and classification of ADRs Describe basic methods to detect, evaluate, and document ADRs. Definition. WHO

★ ★ ★ ★ ★

897 views • 46 slides
Less Is More

Less Is More

Less Is More. Len Paulozzi, MD, MPH. 2014 CSTE Annual Meeting, Nashville, TN, June 25, 2014. Health care spending per person versus life expectancy at birth by country, 2011*. USA. *Or nearest year.

★ ★ ★ ★ ★

391 views • 33 slides
ACCESS TO BETTER HEALTHCARE

ACCESS TO BETTER HEALTHCARE

ACCESS TO BETTER HEALTHCARE.

★ ★ ★ ★ ★

244 views • 20 slides
Within the same individual

Within the same individual

VARIATION IN DRUG RESONSIVNESS. Decrease in drug effects. Development of side effects. Between different individuals. Within the same individual. ilo s. By the end of this lecture you will be able to : .

★ ★ ★ ★ ★

249 views • 15 slides
Protected Health Information (PHI)

Protected Health Information (PHI)

Information about your health is private. And it should remain private. That is why PARADIGM HOUSE is required by federal and state law to protect the privacy of your health information. IT IS CALLED. Protected Health Information (PHI).

★ ★ ★ ★ ★

290 views • 12 slides
Medinfo 2013, Paper Session: Patient Safety and Medical Errors - I

Medinfo 2013, Paper Session: Patient Safety and Medical Errors - I

Medinfo 2013, Paper Session: Patient Safety and Medical Errors - I. It Is Time for Self-Incident-Reporting for Patients and Their Families in Every Health Care Organization: A Literature Review . Kinnunen Ulla-Mari, RN, MHSc , PhD-student, university teacher Saranto Kaija , professor

★ ★ ★ ★ ★

262 views • 12 slides
Multiple Chronic Conditions & Population Health

Multiple Chronic Conditions & Population Health

Multiple Chronic Conditions & Population Health. Anand K. Parekh, MD, MPH Deputy Assistant Secretary for Health (Science & Medicine) Office of Public Health & Science U.S. Department of Health & Human Services September 29, 2008. HHS & Population Health.

★ ★ ★ ★ ★

285 views • 10 slides
Kentucky Hospital Engagement Network

Kentucky Hospital Engagement Network

Kentucky Hospital Engagement Network. OB Collaborative to Reduce Early Elective Delivery. Hospital Engagement Network. CMS funded Program to reduce hospital acquired conditions by 40% and readmissions by 20% by 2013 HENs provide resources to hospitals to achieve goals

★ ★ ★ ★ ★

286 views • 10 slides
The Epidemiology of Sepsis in the United States from 1979 through 2000

The Epidemiology of Sepsis in the United States from 1979 through 2000

The Epidemiology of Sepsis in the United States from 1979 through 2000. Greg S. Martin, M.D., David M. Mannino, M.D., Stephanie Eaton, M.D. and Marc Moss, M.D. N Engl J Med Volume 348;16:1546-1554 April 17, 2003. Study Overview.

★ ★ ★ ★ ★

213 views • 8 slides
Improving Harm Across the Board

Improving Harm Across the Board

Improving Harm Across the Board. The mission of Ozark Health Medical Center is to provide quality healthcare to everyone, always. Ozark Health Medical Center Clinton, AR Edna Prosser, RN, BSN, CNO. 2012 Adverse Drug Event: Medication Error Tracking. Falls With Injury.

★ ★ ★ ★ ★

149 views • 7 slides
Pharmacovigilance Software Market Region Wise Calculation & Analysis Till 2024

Pharmacovigilance Software Market Region Wise Calculation & Analysis Till 2024

The global Pharmacovigilance (PV) software market size was worth 124.92 million in 2016 which is anticipated to grow at a CAGR of more than 6.6% during the forecast period. Increasing cases of Adverse Drug Reactions (ADRs) is the major attributing element for the growth of the PV software market over the forecast period.

★ ★ ★ ★ ★

42 views • 4 slides

View Adverse drug PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Adverse drug PowerPoint presentations. You can view or download Adverse drug presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.